/
SCNI
$0.24+$0.00 (+1.71%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.3M
5M shares
52-week range
$0.21 – $1.96
2% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
ADRC
Change$-13.05
Scinai Immunotherapeutics Ltd. American Depositary Shares
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.
www.scinai.com- Employees
- 45
- IPO / List date
- May 12, 2015
- HQ
- JERUSALEM, L3
Held by traders on TradeandTell
No one on the platform currently holds SCNI.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SCNI as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-08-21 | 1-for-10reverse |
| 2024-05-21 | 1-for-10reverse |
| 2022-11-25 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded SCNI yet.
